Impact of chest physiotherapy on lung function in patients with primary ciliary dyskinesia
The Influence of Chest Physiotherapy on Lung Function Parameters in Primary Ciliary Dyskinesia
This study is trying to see if chest physiotherapy can help improve lung function in people with primary ciliary dyskinesia.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 29 (estimated) |
| Ages | 6 Years to 50 Years |
| Sex | All |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Trial ID | NCT01929356 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of chest physiotherapy on lung function in patients with primary ciliary dyskinesia (PCD), a rare condition characterized by impaired ciliary function leading to respiratory issues. The research aims to determine both the short-term and long-term impacts of chest physiotherapy on lung function, utilizing standardized lung function tests such as spirometry and Multiple Breath Washout measurements. By examining these effects, the study seeks to provide objective data to support the therapeutic use of chest physiotherapy in managing PCD.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with primary ciliary dyskinesia who are able to perform lung function tests and are over the age of 6.
Not a fit: Patients experiencing an acute exacerbation of their condition may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance treatment protocols for patients with primary ciliary dyskinesia, potentially improving their lung function and quality of life.
How similar studies have performed: While chest physiotherapy is a common treatment for respiratory conditions, this specific investigation into its acute effects on lung function in PCD is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary ciliary dyskinesia * able to perform spirometry and MBW (\>6 years) Exclusion Criteria: * acute exacerbation
Where this trial is running
Leuven
- University Hospital Gasthuisberg Leuven — Leuven, Belgium (Recruiting)
Study contacts
- Principal investigator: Mieke Boon, MD — research fellow
- Study coordinator: Mieke Boon, MD
- Email: mieke.boon@uzleuven.be
- Phone: +3216342589
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.